Ligand validation:5NX9

PEG: DI(HYDROXYETHYL)ETHER

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NX9_PEG_D_504	61%	69%	0.133	0.921	0.68	0.52	-	-	0	0	100%	1
5NX9_PEG_B_503	60%	78%	0.123	0.906	0.54	0.37	-	-	1	0	100%	1
5NX9_PEG_A_505	59%	77%	0.143	0.926	0.57	0.35	-	-	0	0	100%	1
5NX9_PEG_A_506	58%	73%	0.126	0.903	0.68	0.37	-	-	0	0	100%	1
5NX9_PEG_C_506	56%	77%	0.147	0.917	0.52	0.39	-	-	0	0	100%	1
5NX9_PEG_C_504	52%	72%	0.112	0.867	0.71	0.39	-	-	0	0	100%	1
5NX9_PEG_C_508	47%	80%	0.147	0.885	0.52	0.33	-	-	0	0	100%	1
5NX9_PEG_A_507	42%	69%	0.165	0.883	0.58	0.6	-	-	0	0	100%	1
5NX9_PEG_C_505	38%	79%	0.138	0.837	0.56	0.32	-	-	0	0	100%	1
5NX9_PEG_A_508	32%	87%	0.133	0.805	0.54	0.17	-	-	0	0	100%	1
5NX9_PEG_D_506	28%	79%	0.154	0.807	0.55	0.32	-	-	0	0	100%	1
5NX9_PEG_A_509	17%	81%	0.223	0.8	0.54	0.29	-	-	1	0	100%	1
5NX9_PEG_D_505	6%	76%	0.301	0.734	0.57	0.39	-	-	0	0	100%	1
5NX8_PEG_C_502	16%	72%	0.266	0.835	0.54	0.55	-	-	4	0	100%	1
3MR0_PEG_B_146	100%	81%	0.029	0.991	0.58	0.26	-	-	0	0	100%	1
4NMU_PEG_D_203	100%	80%	0.027	0.989	0.36	0.47	-	-	1	0	100%	1
4R86_PEG_A_402	100%	82%	0.037	0.991	0.45	0.36	-	-	3	0	100%	1
5VTA_PEG_A_808	100%	75%	0.034	0.985	0.56	0.42	-	-	0	0	100%	1
9K7O_PEG_A_401	100%	97%	0.036	0.987	0.21	0.13	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.